The SIRT3-AMPK pathway activates UPRmt to inhibit cardiac hypertrophy and alleviate cardiac dysfunction [77] independently of CHOP and estrogen receptor α (ERα) pathways [78]. This evidence concerns the gene ESR1 and cardiac hypertrophy.